Myocardial antioxidant and oxidative stress changes due to sex hormones

Brazilian Journal of Medical and Biological Research

Volumn 35, Issue 9, 2002, Pages 1075-1081

  Barp, J ^a   Araujo A S R ^a   Fernandes, T R G ^a   Rigatto, K V ^a   Llesuy, S ^b   Bello Klein A ^a   Singal, P ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Catalase; Glutathione peroxidase; Lipid peroxidation; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; CATALASE; ESTROGEN; GLUTATHIONE PEROXIDASE; SEX HORMONE; SUPEROXIDE DISMUTASE; TESTOSTERONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; CASTRATION; CELL MEMBRANE; CHEMOLUMINESCENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HORMONE DETERMINATION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RADIOIMMUNOASSAY; RAT; RAT STRAIN; REVIEW; SEX DIFFERENCE;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0036763568     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2002000900008     Document Type: Review

References (38)

1. Singal PK, Khaper N, Palace V & Kumar D (1998). The role of oxidative stress in the genesis of heart disease. Cardiovascular Research, 40: 426-432.
2. Wenger NK, Speroff L & Packard B (1993). Cardiovascular health and disease in women. New England Journal of Medicine, 329: 247-256.
3. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW & Wing RR (1989). Menopause and risk factors for coronary heart disease. New England Journal of Medicine, 321: 641-646.
4. Nalbulsi AA, Folsom AR & White A (1993). Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. New England Journal of Medicine, 328: 1069-1075.
5. Ganong WF (1999). Review of Medical Physiology. 19th edn. Appleton & Lange, East Norwalk, CT, USA.
6. Kuhl H (1994). Cardiovascular effects and estrogen/gestagen substitution therapy. Therapeutische Umschau, 51: 748-754.
7. Maffei S & De Caterina R (1996). Hormone replacement therapy and cardiovascular risk. Giornale Italiano di Cardiologia, 26: 899-940.
8. Farhat MY, Lavigne MC & Ramwell PW (1996). The vascular protective effect of estrogen. FASEB Journal, 10: 615-624.
9. Nuedling S, Kahlert S, Loebbert K, Doevendans PA, Meyer R, Vetter H & Grohé C (1999). 17β-Estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in vitro and in vivo. Cardiovascular Research, 43: 666-674.
10. Kuroski de Bold ML (1999). Estrogen, natriuretic peptides and the renin-angiotensin system. Cardiovascular Research, 41: 524-531.
11. Babiker FA, De Windt LJ, van Eickels M, Grohé C, Meyer R & Doevendans PA (2002). Estrogenic hormone action in the heart: regulatory network and function. Cardiovascular Research, 53: 709-719.
12. Grohé C, Kahlert S, Loebbert K, Stimpel M, Karas RH, Vetter H & Neyses L (1997). Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Letters, 416: 107-112.
13. Collins P, Beale CM & Rosano GMC (1996). Oestrogen as a calcium channel blocker. European Heart Journal, 17 (Suppl D): 27-31.
14. Massafra C, De Felice C, Gioia D & Buonocore G (1998). Variations in erythrocyte antioxidant glutathione peroxidase activity during the menstrual cycle. Clinical Endocrinology, 49: 63-67.
15. Sullivan MJ, Green HJ & Cobb FR (1991). Altered skeletal muscle metabolic response to exercise in chronic heart failure: relation to skeletal muscle aerobic enzyme activity. Circulation, 84: 1597-1607.
16. Baker HJ, Lindsey JR & Weisbroth SH (1979). The Laboratory Rat. Vol. 1, Biology and Diseases. Academic Press, New York, NY, USA.
17. Genuth SM (1993). The endocrine system. In: Berne RM & Levy MN (Editors), Physiology. 3rd edn. Mosby-Year Book, Inc., St. Louis, MO, USA.
18. Llesuy SF, Milei J, Molina H, Boveris A & Milei S (1985). Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4′-epiadriamycin in mice. Tumori, 71: 241-249.
19. Marklund S (1985). Pyrogallol autoxidation. In: Greenwald RA (Editor), Handbook of Methods for Oxygen Radical Research. CRC Press, Boca Raton, FL, USA, 243-247.
20. Flohé L & Gunzler WA (1984). Assay of glutathione peroxidase. Methods in Enzymology, 105: 114-121.
21. Chance B, Sies H & Boveris A (1979). Hydroperoxide metabolism in mammalian organs. Physiological Reviews, 59: 527-625.
22. Boveris A & Chance B (1973). The mitochondrial generation of hydrogen peroxide. Biochemical Journal, 134: 707-716.
23. Gonzalez Flecha B, Llesuy S & Boveris A (1991). Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of liver, heart and muscle. Free Radical Biology and Medicine, 10: 41-47.
24. Buege JÁ & Aust SD (1978). Microsomal lipid peroxidation. Methods in Enzymology, 52: 302-309.
25. Lowry OH, Rosebrough AL, Farr AL & Randall R (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193: 265-275.
26. Akcay T, Dincer Y, Kayali R, Colgar U, Oral E & Cakatay U (2000). Effects of postmenopausal women. Journal of Toxicology and Environmental Health, Part A, 59: 1-5.
27. Niki E & Nakano M (1990). Estrogens as antioxicants. Methods in Enzymology, 186: 330-333.
28. Halliwell B & Gutteridge JCM (1999). Free Radicals in Biology and Medicine. 3rd edn. Oxford University Press, New York, NY, USA.
29. Mooradian AD (1993). Antioxidant properties of steroides. Journal of Steroid Biochemistry and Molecular Biology, 45: 509-511.
30. Dantas APV, Scivoletto R, Forles ZB, Nigro D & Carvalho MHC (1999). Influence of female sex hormones on endothelium-derived vasoconstrictor prostanoid generation in microvessels of spontaneously hypertensive rats. Hypertension, 34: 914-919.
31. Barbacanne MA, Rami J, Michel JB, Souchard JP, Philippe M, Besombes JP, Bayard F & Arnal JF (1999). Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production. Cardiovascular Research, 41: 672-681.
32. Kenaley JA & Ji LL (1991). Antioxidant enzyme activity during prolonged exercise in amenorrheic and eumenorrheic athletes. Metabolism: Clinical and Experimental, 40: 88-92.
33. Arnal JF, Clamens S, Pechet C, Negre SA, Allera C, Girolami JP, Salvayre R & Bayard F (1996). Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proceedings of the National Academy of Sciences, USA, 93: 4108-4113.
34. Oberley TD, Shultz JL & Oberley LW (1994). In vivo modulation of antioxidant enzyme levels in normal hamster kidney and estrogen-induced kidney tumor. Free Radical Biology and Medicine, 16: 741-751.
35. Morgan-Martins MI, Marroni C, Vercelino R, Fernandes TRG, Llesuy S, Belló-Klein A and Singal PK (2001). Estrogen effect on blood pressure and oxidative stress in female heart rats. Journal of Molecular and Cellular Cardiology, 33: A78.
36. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T & Inoue M (1991). Does superoxide underlie the pathogenesis of hypertension? Proceedings of the National Academy of Sciences, USA, 88: 10045-10048.
37. Dincer Y, Ozen E, Kadioglu P, Hatemi H & Akcay T (2001). Effect of sex hormones on lipid peroxidation in women with polycystic ovary syndrome, healthy women, and men. Endocrine Research, 27: 309-316.
38. Belló-Klein A, Morgan-Martins MI, Barp J, Llesuy S, Belló AA & Singal PK (2000). Circaannual changes in antioxidants and oxidative stress in the heart and liver in rats. Comparative Biochemistry and Physiology. Part C, 126: 203-208.